Get the Stockscreener App
16.22
2.58%
-0.43
After Hours:
16.33
0.11
+0.68%
Overview
News
Price History
Option Chain
Financials
Why KVUE Down?
Discussions
Forecast
Dividend History
Kenvue Inc stock is traded at $16.22, with a volume of 21.98M.
It is down -2.58% in the last 24 hours and down -14.59% over the past month.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
See More
Previous Close:
$16.65
Open:
$16.56
24h Volume:
21.98M
Relative Volume:
0.83
Market Cap:
$31.13B
Revenue:
$15.14B
Net Income/Loss:
$1.42B
P/E Ratio:
22.04
EPS:
0.7361
Net Cash Flow:
$1.63B
1W Performance:
+3.38%
1M Performance:
-14.59%
6M Performance:
-26.57%
1Y Performance:
-24.42%
1-Day Range:
$16.14
$16.64
1-Week Range:
$15.64
$16.95
52-Week Range:
$15.47
$25.17
Kenvue Inc Stock (KVUE) Company Profile
Name
Kenvue Inc
Sector
Industry
Phone
908-874-1200
Address
1 KENVUE WAY, SUMMIT
Compare KVUE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
16.22 | 31.95B | 15.14B | 1.42B | 1.63B | 0.7361 |
|
PG
Procter Gamble Co
|
147.49 | 350.35B | 84.28B | 16.07B | 14.05B | 6.5067 |
|
UL
Unilever Plc Adr
|
60.09 | 148.17B | 64.99B | 6.71B | 6.53B | 2.4355 |
|
CL
Colgate Palmolive Co
|
76.98 | 63.01B | 20.00B | 3.05B | 3.37B | 3.5578 |
|
KMB
Kimberly Clark Corp
|
119.27 | 39.67B | 18.88B | 2.38B | 2.10B | 7.2549 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-26-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Apr-10-25 | Initiated | Redburn Atlantic | Neutral |
| Mar-24-25 | Initiated | Evercore ISI | In-line |
| Jan-06-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-12-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Sep-24-24 | Initiated | Jefferies | Buy |
| Sep-24-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-28-24 | Resumed | Citigroup | Neutral |
| Apr-11-24 | Initiated | Bernstein | Underperform |
| Apr-03-24 | Initiated | William Blair | Mkt Perform |
| Mar-01-24 | Resumed | Goldman | Neutral |
| Nov-17-23 | Initiated | Piper Sandler | Neutral |
| Sep-11-23 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-07-23 | Initiated | Canaccord Genuity | Buy |
| Sep-06-23 | Initiated | Argus | Hold |
| Aug-24-23 | Upgrade | Goldman | Neutral → Buy |
| Jul-25-23 | Initiated | Edward Jones | Buy |
| Jun-01-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Initiated | BofA Securities | Buy |
| May-30-23 | Initiated | Citigroup | Neutral |
| May-30-23 | Initiated | Deutsche Bank | Hold |
| May-30-23 | Initiated | Exane BNP Paribas | Neutral |
| May-30-23 | Initiated | Goldman | Neutral |
| May-30-23 | Initiated | JP Morgan | Overweight |
| May-30-23 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Initiated | UBS | Neutral |
View All
Kenvue Inc Stock (KVUE) Latest News
Traders Buy High Volume of Kenvue Call Options (NYSE:KVUE) - MarketBeat
Using RSI to spot recovery in Kenvue Inc.Market Movement Recap & AI Based Buy and Sell Signals - newser.com
Will Kenvue Inc. stock split again soonWatch List & Community Verified Swing Trade Signals - newser.com
Kenvue’s SWOT analysis: stock faces challenges amid tylenol controversy - Investing.com
Kenvue’s SWOT analysis: stock faces challenges amid tylenol controversy By Investing.com - Investing.com UK
Using data tools to time your Kenvue Inc. exit2025 Geopolitical Influence & Verified Momentum Stock Alerts - newser.com
What high frequency data says about Kenvue Inc.Weekly Stock Analysis & AI Based Trade Execution Alerts - newser.com
What earnings revisions data tells us about Kenvue Inc.July 2025 Selloffs & AI Forecast for Swing Trade Picks - newser.com
Will Kenvue Inc. stock outperform tech sector in 2025Weekly Risk Summary & Precise Buy Zone Tips - newser.com
Kenvue Inc. $KVUE Shares Bought by OFI Invest Asset Management - MarketBeat
Vest Financial LLC Has $48.74 Million Stake in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. $KVUE Holdings Raised by Blair William & Co. IL - MarketBeat
US Bancorp DE Sells 36,862 Shares of Kenvue Inc. $KVUE - MarketBeat
Will Kenvue Inc. stock maintain momentum in 2025GDP Growth & Weekly High Conviction Trade Ideas - newser.com
Rep. Val T. Hoyle Sells Kenvue Inc. (NYSE:KVUE) Shares - MarketBeat
Moody’s Ratings Downgrades Kenvue Inc. (KVUE) Outlook from “Stable” to “Negative” - Yahoo
JPMorgan Chase & Co. Cuts Kenvue (NYSE:KVUE) Price Target to $21.00 - MarketBeat
Total Wealth Planning & Management Inc. Takes Position in Kenvue Inc. $KVUE - MarketBeat
Pinion Investment Advisors LLC Lowers Stock Position in Kenvue Inc. $KVUE - MarketBeat
Tylenol Turmoil: Partisan Politics Fuel Confusion Over Pregnancy Risks, Poll Shows - Benzinga
Kenvue (NYSE:KVUE) Price Target Lowered to $17.00 at Citigroup - MarketBeat
Comparing Kenvue Inc. in custom built stock radarsQuarterly Portfolio Report & Expert Curated Trade Setups - newser.com
Developing predictive dashboards with Kenvue Inc. dataWeekly Gains Summary & Technical Buy Zone Confirmations - newser.com
JPMorgan Adjusts Price Target on Kenvue to $21 From $24, Maintains Overweight Rating - MarketScreener
Is Kenvue Inc. (J4D) stock a buy for dividend portfoliosMarket Risk Analysis & Daily Profit Focused Screening - newser.com
What’s the recovery path for long term holders of Kenvue Inc.Weekly Trend Recap & Verified Short-Term Plans - newser.com
Columbus Macro LLC Increases Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
Is This Beaten-Down Dividend King a Buy? - AOL.com
Is This Beaten-Down Dividend King a Buy? - The Motley Fool
Is it too late to sell Kenvue Inc.Weekly Gains Summary & Technical Entry and Exit Tips - newser.com
Buy 2 Ideal Dividend Kings Of 25 'Safer' In October’s 56 - Seeking Alpha
How Kenvue Inc. (J4D) stock performs in easing cycles2025 Trade Ideas & Real-Time Stock Price Movement Reports - newser.com
How Kenvue (KVUE) Earned its Spot Among Today’s Most Promising Dividend Stocks - Yahoo Finance
Kenvue’s Brand Strength Tested After Johnson & Johnson Spinoff - Finimize
Citigroup Maintains Kenvue (KVUE) Neutral Recommendation - Nasdaq
Johnson & Johnson to Participate in the UBS Global Healthcare Conference - Investing News Network
Kenvue Stock Rebound: A Buying Opportunity? - timothysykes.com
Kenvue Inc. stock rises Thursday, outperforms market - MarketWatch
Bullish flow in Kenvue Inc with shares up 4.7% - TipRanks
Kenvue’s Resurgence: New Opportunities or Risks? - StocksToTrade
November 28th Options Now Available For Kenvue (KVUE) - Nasdaq
US Republicans and Democrats split on party lines on Trump's Tylenol-autism claimKFF poll - MarketScreener
Is Kenvue Inc. stock a buy in volatile marketsEntry Point & Daily Oversold Bounce Ideas - newser.com
Chart based analysis of Kenvue Inc. trends2025 Valuation Update & Precise Buy Zone Tips - newser.com
Kenvue Inc. $KVUE Shares Sold by Belpointe Asset Management LLC - MarketBeat
Is Kenvue Inc. a candidate for recovery play2025 Price Targets & Weekly High Return Opportunities - newser.com
QRG Capital Management Inc. Buys 29,813 Shares of Kenvue Inc. $KVUE - MarketBeat
B of A Securities Maintains Kenvue (KVUE) Buy Recommendation - Nasdaq
UBS Maintains Kenvue (KVUE) Neutral Recommendation - Nasdaq
Donald Trump’s Tylenol Warning Makes Kenvue Stock (KVUE) an Opportunity in Disguise - TipRanks
Kenvue (KVUE): Exploring Valuation After Recent Share Price Weakness - Yahoo Finance
Kenvue Inc Stock (KVUE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Kenvue Inc Stock (KVUE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Dyer Russell | Chief Corp. Affairs Officer |
Jun 03 '25 |
Option Exercise |
0.00 |
2,669 |
0 |
2,669 |
0.25%
5.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):